Investor’s Business Daily | Stock News and Stock Market Analysis
Perform stock investment research with our IBD research tools to help investment strategies. We provide the resources to help make informed decisions.
Log in · Dow Jones - Investor's Business Daily
Your sign in credentials (email and password) may be used to access certain other Dow Jones branded products.
Login - Investors.com
Keep me signed in Sign In Signing in... Sign In Signing in...
News | Investor's Business Daily
6 days ago · IBD covers timely business, technology and economic news, focusing on key market-moving trends and top stocks. News stories include stock technical analysis. Market …
Stock Research & Analysis Platform - Investor’s Business Daily
MarketSurge from IBD is the most powerful stock analysis and research platform available to individual investors helping you quickly analyze stocks and find the right time to buy or sell.
IBD Digital And Print - Investor’s Business Daily
See how IBD Digital ® + Print has helped retail traders navigate the market and streamline their investing for over 35 years. 2 Months for $14. No obligation. Try 2 months of IBD Digital + …
SwingTrader - Swing Trading Tool from IBD - Investor’s Business …
SwingTrader is the only swing trading product that utilizes The IBD Methodology to identify trade ideas and calculate optimal buy and sell prices. This system, created by legendary investor …
The Big Picture | Investor's Business Daily
6 days ago · The IBD 50, which found support at its 50-day line the past few days, outperformed with a brilliant 4.2% jump. Stock Market Climbs, But Cava, Spotify, Small Caps Sink; Could …
IBD Live - Investor’s Business Daily
IBD Live is an interactive broadcast where our stock pickers, analysts and portfolio managers watch the market action and discuss the day’s top trade ideas. Listen to their conversations, …
Stock Lists - IBD 50 | Investor's Business Daily
Jan 10, 2025 · Two health care stocks have earned their spot on the IBD 50 after a strong run in 2024. Globus Medical and GeneDx are also near buy points as they continue to outperform. …